New Brunswick, NJ, United States of America

Dilbir S Bindra

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 6.2

ph-index = 5

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Dilbir S Bindra: Innovator in Pharmaceutical Composition**

Introduction

Dilbir S Bindra, hailing from New Brunswick, NJ, has made significant strides in the field of pharmaceutical innovations. With a remarkable portfolio of seven patents, his work focuses on developing novel compositions with potent therapeutic applications, particularly in the treatment of cancer and other proliferative diseases.

Latest Patents

Among his latest inventions, Bindra has patented pharmaceutical compositions comprising complex chemical entities, such as N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide. This invention includes various salts and crystalline forms of the compound, as well as methods to utilize these forms in treating diseases. Another notable patent includes pharmaceutical formulations containing an SGLT2 inhibitor, specifically designed for oral administration in capsule or tablet form, optimized for immediate release.

Career Highlights

Dilbir Bindra's career has been marked by his contributions to renowned pharmaceutical companies. He has lent his expertise to institutions such as Bristol-Myers Squibb Company and AstraZeneca AB, where his innovations have had substantive impacts on drug formulation and development. His extensive knowledge in the field has equipped him to tackle complex challenges in pharmaceutical research and development.

Collaborations

Bindra has collaborated with fellow innovators in the industry, such as Mandar V Dali and Prakash V Parab. Together, they have worked on advancing pharmaceutical compositions and exploring novel therapeutic pathways to improve patient outcomes. These collaborations highlight the importance of teamwork and shared vision in driving pharmaceutical advancements.

Conclusion

Dilbir S Bindra stands out as a notable inventor in the pharmaceutical domain. His innovative solutions and commitment to improving medical treatments through advanced compositions underscore the vital role of inventors in the healthcare industry. With numerous patents to his name, Bindra continues to pave the way for future innovations in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…